Ron Zwanziger
Chief Executive Officer chez LUMIRADX LIMITED
Fortune : 5 M $ au 31/12/2023
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Jerome McAleer | M | 68 |
Inverness Medical Technology, Inc.
Inverness Medical Technology, Inc. Pharmaceuticals: OtherHealth Technology Inverness Medical Technology, Inc. develops, manufactures and markets healthcare products for diabetes and for women through its retail distribution networks. The company was incorporated in September 9, 1992 and is headquartered in Waltham, Massachusetts.
LumiraDx UK Ltd.
LumiraDx UK Ltd. Medical SpecialtiesHealth Technology Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The private company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then.
LumiraDx Group Ltd.
LumiraDx Group Ltd. Medical SpecialtiesHealth Technology Part of LumiraDx Ltd. (Cayman Islands), LumiraDx Group Ltd. is a next generation point of care diagnostic platform that was founded in 2014. The private company is based in London, UK and is transforming community-based healthcare with lab comparable results in minutes. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing by utilizing its innovative qSTAR nucleic acid amplification technology in an accessible high-throughput format to leverage current molecular laboratory operations.
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands.
LumiraDx International Ltd.
LumiraDx International Ltd. Medical DistributorsDistribution Services Part of LumiraDx Ltd. (Cayman Islands), LumiraDx International Ltd. is a wholesaler of pharmaceutical goods. The private company is based in London, UK. LumiraDx International was founded in 2014. | 25 ans |
Dave Scott | M | 67 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands.
LumiraDx Group Ltd.
LumiraDx Group Ltd. Medical SpecialtiesHealth Technology Part of LumiraDx Ltd. (Cayman Islands), LumiraDx Group Ltd. is a next generation point of care diagnostic platform that was founded in 2014. The private company is based in London, UK and is transforming community-based healthcare with lab comparable results in minutes. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing by utilizing its innovative qSTAR nucleic acid amplification technology in an accessible high-throughput format to leverage current molecular laboratory operations.
LumiraDx International Ltd.
LumiraDx International Ltd. Medical DistributorsDistribution Services Part of LumiraDx Ltd. (Cayman Islands), LumiraDx International Ltd. is a wholesaler of pharmaceutical goods. The private company is based in London, UK. LumiraDx International was founded in 2014.
LumiraDx UK Ltd.
LumiraDx UK Ltd. Medical SpecialtiesHealth Technology Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The private company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then. | 23 ans |
Julia Lurene | F | 64 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands.
LumiraDx UK Ltd.
LumiraDx UK Ltd. Medical SpecialtiesHealth Technology Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The private company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then. | 9 ans |
Donald Berwick | M | 77 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands.
LumiraDx UK Ltd.
LumiraDx UK Ltd. Medical SpecialtiesHealth Technology Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The private company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then. | 6 ans |
Dorian LeBlanc | M | 49 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | 12 ans |
George Neble | M | 67 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands.
LumiraDx UK Ltd.
LumiraDx UK Ltd. Medical SpecialtiesHealth Technology Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The private company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then. | 4 ans |
Fauzia M. Khan | M | - |
Persivia, Inc.
Persivia, Inc. Packaged SoftwareTechnology Services Persivia, Inc. provides a clinical decision support and reporting analytics platform. It aggregates, analyzes and reports clinical data sets in the healthcare industry. The firm offers patient-centric clinical decision support, population health management, intelligent order sets, disease surveillance and regulatory reporting services. The company was founded by Mansoor Khan and is headquartered in Lowell, MA.
Persivia Holdings, Inc.
Persivia Holdings, Inc. Financial ConglomeratesFinance Persivia Holdings, Inc. engages in the provision of holdings services. The company was founded in 2015 and is headquartered in Lowell, MA. | - |
Lu Huang | M | 50 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands.
LumiraDx UK Ltd.
LumiraDx UK Ltd. Medical SpecialtiesHealth Technology Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The private company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then. | 6 ans |
Mansoor Khan | M | - |
Persivia Holdings, Inc.
Persivia Holdings, Inc. Financial ConglomeratesFinance Persivia Holdings, Inc. engages in the provision of holdings services. The company was founded in 2015 and is headquartered in Lowell, MA.
Persivia, Inc.
Persivia, Inc. Packaged SoftwareTechnology Services Persivia, Inc. provides a clinical decision support and reporting analytics platform. It aggregates, analyzes and reports clinical data sets in the healthcare industry. The firm offers patient-centric clinical decision support, population health management, intelligent order sets, disease surveillance and regulatory reporting services. The company was founded by Mansoor Khan and is headquartered in Lowell, MA. | - |
Bruce Keogh | M | 69 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands.
LumiraDx UK Ltd.
LumiraDx UK Ltd. Medical SpecialtiesHealth Technology Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The private company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then. | 6 ans |
Pooja Pathak | F | 46 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | 10 ans |
David Walton | M | 70 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | 17 ans |
Veronique Ameye | F | 47 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | 17 ans |
Nigel Lindner | M | 67 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | 13 ans |
Troyen Brennan | M | 69 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands.
LumiraDx UK Ltd.
LumiraDx UK Ltd. Medical SpecialtiesHealth Technology Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The private company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then. | 8 ans |
Amit N. Thakker | M | 56 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands.
LumiraDx UK Ltd.
LumiraDx UK Ltd. Medical SpecialtiesHealth Technology Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The private company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then. | - |
Lok Chung Chan | M | 73 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | 4 ans |
Thomas Quinlan | M | 61 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | 7 ans |
Gerald R. Chan | M | - |
LumiraDx UK Ltd.
LumiraDx UK Ltd. Medical SpecialtiesHealth Technology Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The private company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then.
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | - |
Edward Cahill | M | 71 |
Persivia Holdings, Inc.
Persivia Holdings, Inc. Financial ConglomeratesFinance Persivia Holdings, Inc. engages in the provision of holdings services. The company was founded in 2015 and is headquartered in Lowell, MA.
Persivia, Inc.
Persivia, Inc. Packaged SoftwareTechnology Services Persivia, Inc. provides a clinical decision support and reporting analytics platform. It aggregates, analyzes and reports clinical data sets in the healthcare industry. The firm offers patient-centric clinical decision support, population health management, intelligent order sets, disease surveillance and regulatory reporting services. The company was founded by Mansoor Khan and is headquartered in Lowell, MA. | - |
Peter Welch | M | - | 4 ans | |
Christopher Mills | M | 72 | 8 ans | |
Peter Geoffrey Welch | M | 72 |
Treisar Investments Ltd.
Treisar Investments Ltd. Financial ConglomeratesFinance Treisar Investments Ltd. provides investment services. The private company is based in London, UK and was founded in 2015. | - |
Tadd Seaton Wessel | M | - |
Persivia, Inc.
Persivia, Inc. Packaged SoftwareTechnology Services Persivia, Inc. provides a clinical decision support and reporting analytics platform. It aggregates, analyzes and reports clinical data sets in the healthcare industry. The firm offers patient-centric clinical decision support, population health management, intelligent order sets, disease surveillance and regulatory reporting services. The company was founded by Mansoor Khan and is headquartered in Lowell, MA. | - |
Mino Green | M | - |
Imperial College London
| 52 ans |
Saar Shafir | M | 49 |
Treisar Investments Ltd.
Treisar Investments Ltd. Financial ConglomeratesFinance Treisar Investments Ltd. provides investment services. The private company is based in London, UK and was founded in 2015. | - |
Melissa Garcia | F | - | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Frank Thomas | M | 54 | 6 ans | |
Jerome Goldstein | M | 84 | 26 ans | |
Paul T. Hempel | M | 75 |
Inverness Medical Technology, Inc.
Inverness Medical Technology, Inc. Pharmaceuticals: OtherHealth Technology Inverness Medical Technology, Inc. develops, manufactures and markets healthcare products for diabetes and for women through its retail distribution networks. The company was incorporated in September 9, 1992 and is headquartered in Waltham, Massachusetts. | 1 ans |
Namal Nawana | M | 53 | 5 ans | |
Scott A. Holmes | M | 50 | 4 ans | |
David Toohey | M | 67 |
Inverness Medical Technology, Inc.
Inverness Medical Technology, Inc. Pharmaceuticals: OtherHealth Technology Inverness Medical Technology, Inc. develops, manufactures and markets healthcare products for diabetes and for women through its retail distribution networks. The company was incorporated in September 9, 1992 and is headquartered in Waltham, Massachusetts. | 13 ans |
John F. Levy | M | 77 |
Inverness Medical Technology, Inc.
Inverness Medical Technology, Inc. Pharmaceuticals: OtherHealth Technology Inverness Medical Technology, Inc. develops, manufactures and markets healthcare products for diabetes and for women through its retail distribution networks. The company was incorporated in September 9, 1992 and is headquartered in Waltham, Massachusetts. | 5 ans |
Carol R. Goldberg | F | 93 |
Inverness Medical Technology, Inc.
Inverness Medical Technology, Inc. Pharmaceuticals: OtherHealth Technology Inverness Medical Technology, Inc. develops, manufactures and markets healthcare products for diabetes and for women through its retail distribution networks. The company was incorporated in September 9, 1992 and is headquartered in Waltham, Massachusetts. | 9 ans |
Ellen Chiniara | F | 65 | - | |
Michael Narachi | M | 64 | 8 ans | |
Peter Scheu | M | 59 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | 16 ans |
Gregg Joseph Powers | M | 61 | - | |
Brian Pereira | M | 65 | 7 ans | |
Hilde Eylenbosch | M | 61 |
Inverness Medical Technology, Inc.
Inverness Medical Technology, Inc. Pharmaceuticals: OtherHealth Technology Inverness Medical Technology, Inc. develops, manufactures and markets healthcare products for diabetes and for women through its retail distribution networks. The company was incorporated in September 9, 1992 and is headquartered in Waltham, Massachusetts. | 12 ans |
Paul Foulger | M | 55 | 10 ans | |
Peter Townsend | M | 89 |
Inverness Medical Technology, Inc.
Inverness Medical Technology, Inc. Pharmaceuticals: OtherHealth Technology Inverness Medical Technology, Inc. develops, manufactures and markets healthcare products for diabetes and for women through its retail distribution networks. The company was incorporated in September 9, 1992 and is headquartered in Waltham, Massachusetts. | 5 ans |
Eli Y. Adashi | M | 79 | - | |
Tito Adolfo Bacarese-Hamilton | M | 66 | 1 ans | |
Sven Håkan Björklund | M | 68 | - | |
Joseph Vincent Bonventre | M | 74 | 5 ans | |
Jon Russell | M | 59 | - | |
Kok Cheong Thong | M | 77 |
Imperial College London
| 7 ans |
Amy Sullivan | F | 54 | - | |
Yan Cheong Chan | M | 71 |
Imperial College London
| 5 ans |
Kevin William Wilson | M | 72 | 6 ans | |
Ying Sheung Cheung | M | 70 |
Imperial College London
| 8 ans |
Regina Benjamin | M | 67 | 2 ans | |
Bradley Saenger | M | 50 | 6 ans | |
Yee Tung Wong | M | 77 |
Imperial College London
| 5 ans |
Doris-Ann Williams | F | 63 | 1 ans | |
Parvinder S. Hyare | M | - | - | |
Amr Ali Baghdadi | M | - |
Imperial College London
| 5 ans |
David A. Teitel | M | 59 | 12 ans | |
Jim Post | M | - | 3 ans | |
Michael K. Bresson | M | 66 | 1 ans | |
Robert P. Khederian | M | 71 | - | |
Robert Perez | M | 59 | 11 ans | |
Robert DiTullio | M | 70 | - | |
John Yonkin | M | 64 |
Inverness Medical Technology, Inc.
Inverness Medical Technology, Inc. Pharmaceuticals: OtherHealth Technology Inverness Medical Technology, Inc. develops, manufactures and markets healthcare products for diabetes and for women through its retail distribution networks. The company was incorporated in September 9, 1992 and is headquartered in Waltham, Massachusetts. | 4 ans |
Edward C. English | M | 57 | 4 ans | |
John Quelch | M | 73 | - | |
Thomas Fulton Wilson McKillop | M | 81 | - | |
Davey Scoon | M | 78 | 14 ans | |
Lesley Russell | M | 63 | 10 ans | |
Stephen MacMillan | M | 60 | - | |
Geoffrey H. Jenkins | M | 72 |
MediSense, Inc.
MediSense, Inc. Medical SpecialtiesHealth Technology MediSense, Inc. provides blood-glucose monitoring systems. Its products are used to monitor sugar levels in diabetes people. The company was founded in 1996 and is located in Bedford, MA | 18 ans |
James Roosevelt | M | 78 | - | |
Brian Markison | M | 64 | - | |
Timothy G. Healey | M | 58 | - | |
Derek Thomas Welch | M | 55 | 2 ans | |
Mark Hope | M | - |
Imperial College London
| 1 ans |
Richard Sandford | M | - |
Imperial College London
| 4 ans |
Chris Lindop | M | 67 | 3 ans | |
Christopher St. John | M | 77 |
Imperial College London
| 3 ans |
Kai Leung Yung | M | 74 |
Imperial College London
| 1 ans |
John Loughhead | M | - |
Imperial College London
| 8 ans |
Yik Keung Chan | M | 72 |
Imperial College London
| 4 ans |
Christopher J. V. Wheatley | M | - |
Imperial College London
| 2 ans |
Jerzy Jozef Gabrielczyk | M | - |
Imperial College London
| 3 ans |
Alan W. Halsey | M | 74 |
Imperial College London
| 4 ans |
Antonakis Antoniou | M | 69 |
Imperial College London
| 6 ans |
Themistoklis Lekkas | M | 81 |
Imperial College London
| 3 ans |
Ian Read | M | 71 |
Imperial College London
| 4 ans |
Siaou-Sze Lien | F | 74 |
Imperial College London
| 1 ans |
Russell Grant | M | - |
Imperial College London
| 4 ans |
Razman bin Ariffin | M | 76 |
Imperial College London
| 4 ans |
Alfred M. Zeien | M | 94 | 6 ans | |
John Keenan | M | - |
Imperial College London
| 1 ans |
Neil Blackley | M | 69 |
Imperial College London
| 3 ans |
Meng Huat Ang | M | 69 |
Imperial College London
| 4 ans |
David B. Knowles | M | - |
Imperial College London
| 3 ans |
Boon Hwee Koh | M | 73 |
Imperial College London
| 4 ans |
Richard K. Lester | M | - |
Imperial College London
| 4 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 66 | 66,00% |
Royaume-Uni | 45 | 45,00% |
Îles Cayman | 18 | 18,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Ron Zwanziger
- Réseau Personnel